These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11744818)

  • 41. Kidney involvement in systemic sclerosis.
    Steen VD
    Presse Med; 2014 Oct; 43(10 Pt 2):e305-14. PubMed ID: 25174767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Scleroderma renal crisis sine scleroderma in pregnancy: a case report.
    Gore JE; Brown AN
    Clin Exp Rheumatol; 2006; 24(1):87-8. PubMed ID: 16539825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Scleroderma renal crisis in progressive systemic sclerosis: a case report.
    Furukawa A; Hashine K; Miyamoto T; Tamura M; Numata A; Yuasa M; Imagawa A; Kagawa S
    Hinyokika Kiyo; 1990 Dec; 36(12):1451-4. PubMed ID: 2075883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scleroderma renal crisis, still a life-threatening complication.
    Teixeira L; Mahr A; Berezné A; Noël LH; Guillevin L; Mouthon L
    Ann N Y Acad Sci; 2007 Jun; 1108():249-58. PubMed ID: 17893990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnosis, management and prevention of scleroderma renal disease.
    Penn H; Denton CP
    Curr Opin Rheumatol; 2008 Nov; 20(6):692-6. PubMed ID: 18946330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anti-RNA polymerase III antibodies in scleroderma renal crisis].
    Schorn R; Gaspert A; Cohen CD
    Dtsch Med Wochenschr; 2010 Jun; 135(22):1118-21. PubMed ID: 20503137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Renal crisis in scleroderma].
    Fagel WJ; van Es LA
    Ned Tijdschr Geneeskd; 1992 Dec; 136(52):2588-90. PubMed ID: 1480244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scleroderma renal crisis as an initial presentation of systemic sclerosis: a case report and review of the literature.
    Logee KM; Lakshminarayanan S
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S171-4. PubMed ID: 25797912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enalapril (10 mg/day) in systemic sclerosis. One year, double blind, randomised study (ESS-1): pulmonary substudy--effects of three month treatment.
    Ostrowski S; Chibowska M; Biłan A; Palusiński R; Weglarz J; Makaruk B; Krasowska D; Hanzlik J
    Adv Exp Med Biol; 1999; 455():289-93. PubMed ID: 10599357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal manifestations of systemic sclerosis--clinical features and outcome assessment.
    Denton CP
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v54-6. PubMed ID: 18784147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is scleroderma renal crisis with anti-centromere antibody-positive limited cutaneous systemic sclerosis overlooked in patients with hypertension and/or renal dysfunction?
    Sugimoto T; Sanada M; Kashiwagi A
    Nephrology (Carlton); 2008 Apr; 13(2):179-80. PubMed ID: 18275510
    [No Abstract]   [Full Text] [Related]  

  • 52. [Treatment of scleroderma].
    Mouthon L
    Rev Prat; 2002 Nov; 52(17):1915-7. PubMed ID: 12532869
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.
    Frimodt-Møller M; Høj Nielsen A; Strandgaard S; Kamper AL
    Nephrol Dial Transplant; 2010 Mar; 25(3):842-7. PubMed ID: 19903661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pregnancy in scleroderma.
    Steen VD
    Rheum Dis Clin North Am; 2007 May; 33(2):345-58, vii. PubMed ID: 17499711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease.
    Chrysostomou A; Becker G
    N Engl J Med; 2001 Sep; 345(12):925-6. PubMed ID: 11565535
    [No Abstract]   [Full Text] [Related]  

  • 57. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme.
    Falk RJ; Scheinman J; Phillips G; Orringer E; Johnson A; Jennette JC
    N Engl J Med; 1992 Apr; 326(14):910-5. PubMed ID: 1542341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat.
    Jackson B; Franze L; Sumithran E; Johnston CI
    J Lab Clin Med; 1990 Jan; 115(1):21-7. PubMed ID: 2299253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of acute pharmacological blockade of the renin-angiotensin system on intrarenal hemodynamics in patients with systemic lupus erythematosus and systemic scleroderma].
    Bugrova OV; Kutyrina IM; Bagirova VV; Morozova EV; Gromova MM
    Ter Arkh; 2001; 73(6):20-5. PubMed ID: 11521515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Scleroderma renal crisis: a high index of suspicion speeds diagnosis and life-saving treatment.
    Medsger TA; Rodriguez-Reyna TS
    South Med J; 2006 Aug; 99(8):799-800. PubMed ID: 16929870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.